Latest S-1 registration statements

WhiteFiber, Inc. has filed to register an additional 1,796,875 ordinary shares, including over-allotment options, for its ongoing public offering.

ECD Automotive Design, a luxury custom car builder, faces significant financial challenges including a going concern warning, Nasdaq delisting threats, and an SEC investigation, despite reporting improved gross margins and strategic growth initiatives.

Velo3D, a metal 3D printing company, is offering 2.78 million common shares to raise $15.0 million, while facing substantial doubt about its ability to continue as a going concern and reporting significant operating losses.

Iron Horse Acquisitions Corp. II, a blank check company led by experienced SPAC and media executives, is launching a $200 million initial public offering to pursue business combinations in the media and entertainment industry.

FG Merger III Corp., a blank check company, filed an S-1/A for its initial public offering of 20 million units at $10.00 each, targeting the North American financial services industry.

Spring Valley Acquisition Corp. III, a blank check company, is launching a $150 million initial public offering to target businesses in the natural resources and decarbonization industries.

Osprey Bitcoin Trust files an S-1 registration statement with the SEC to list its shares on Cboe BZX Exchange, aiming to convert its OTCQX-traded units into a continuously offered, arbitrage-enabled Bitcoin investment vehicle.

Picard Medical, Inc. is pursuing an initial public offering of 4.25 million shares at $3.50-$4.50 per share to fund operations and product development, despite a history of significant net losses and substantial doubt about its ability to continue as a going concern.

N2OFF, Inc. reports continued operating losses and substantial doubt about its ability to continue as a going concern, while pursuing strategic shifts in agri-food tech and renewable energy, and seeking significant capital through equity agreements.

Nova LifeStyle, Inc. filed an S-1/A amendment to register a continuous offering of up to $9 million in common stock and warrants, while disclosing recent private placements at declining share prices.

Heartflow, Inc. files for an initial public offering of 16.67 million shares at $17.00-$18.00 to fund growth in its AI-driven coronary artery disease diagnostic platform.

Quantumsphere Acquisition Corporation filed an S-1MEF to register an additional 1.38 million units for its public offering, including over-allotment options.

Veea Inc. is offering up to $9 million in common stock and warrants to fund operations, despite significant recurring losses and a substantial accumulated deficit.

FreeCast, Inc. files Amendment No. 7 to its S-1 registration statement, detailing its planned Nasdaq Global Market direct listing of 19,777,502 Class A common shares and updated financial results, while acknowledging substantial doubt about its going concern ability.

Bunker Hill Mining Corp. completed a significant capital restructuring and equity financing totaling approximately $26.7 million, alongside debt conversions and royalty amendments, to fund the restart of its Idaho mine.

Starry Sea Acquisition Corp filed its fifth amendment to its S-1 registration statement, primarily updating legal opinions and auditor consents for its proposed public offering of up to 5.75 million units.

Odyssey Health Incorporated filed an S-1 registration statement to allow Mast Hill Fund, L.P. to resell 20 million shares and potentially raise up to $25 million for general corporate purposes.

Freedom Holdings, Inc. (FHLD) files S-1/A, revealing substantial doubt about its ability to continue as a going concern, material financial restatements, and its auditor facing SEC fraud charges.

Shuttle Pharmaceuticals Holdings, Inc. filed an S-1 registration statement for the resale of 1,180,877 shares of common stock by a selling stockholder, stemming from a recent private placement.

Maison Solutions Inc. filed an S-1/A to register 14 million shares for resale by a selling stockholder, signaling significant potential dilution and highlighting Nasdaq compliance issues.

Sunshine Biopharma Inc. filed an S-1 registration statement to allow for the cash exercise of 15.5 million Series B Warrants, potentially raising $32 million, while navigating ongoing Nasdaq listing compliance challenges.

BRB Foods Inc. filed an S-1/A amendment, detailing estimated IPO expenses of $727,607, recent convertible note offerings, and confirming the legality of up to 3.75 million IPO shares.

M3-Brigade Acquisition VI Corp., a newly formed blank check company, is launching a $300 million initial public offering to seek business combinations, primarily targeting the cryptocurrency, blockchain, and sustainability sectors.

Aureus Greenway Holdings Inc. reports a net loss for fiscal year 2024 and decreased Q1 2025 revenue, while addressing a Nasdaq minimum bid price non-compliance notice and completing recent capital raises.

General Enterprise Ventures, Inc. (GEVI) filed an S-1/A for a public offering of 1.5 million common shares, a 1-for-6 reverse stock split, and an NYSE American listing, despite ongoing financial losses and a going concern qualification.

Scilex Holding Company files an S-1 registration statement for the resale of up to 1.39 million common shares by Tumim Stone Capital, securing a potential $100 million equity financing to bolster its non-opioid pain management portfolio and operations.

Capstone Holding Corp. filed an S-1 registration statement for the resale of over 4 million common shares by a selling stockholder, stemming from a recent convertible note financing.

Firefly Aerospace is launching its initial public offering, seeking up to $731.3 million to fuel expansion and debt repayment, despite recent operational setbacks and ongoing net losses.

OS Therapies Incorporated filed an S-1 registration statement to allow selling stockholders to resell up to 3.76 million common shares issued from a recent warrant exercise inducement, which generated over $4.2 million in gross proceeds for the company.

Longeveron Inc. files an S-1 registration statement to raise up to $5.2 million through a public offering of common stock and warrants to fund ongoing clinical trials for its lead product, laromestrocel.